Handelsbanken Fonder AB grew its position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 14.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,437 shares of the company's stock after acquiring an additional 2,100 shares during the quarter. Handelsbanken Fonder AB's holdings in Molina Healthcare were worth $5,414,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently modified their holdings of the company. Rothschild Investment LLC raised its holdings in shares of Molina Healthcare by 126.3% in the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after purchasing an additional 48 shares during the last quarter. Colonial Trust Co SC boosted its holdings in Molina Healthcare by 930.0% in the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after buying an additional 93 shares during the period. Hurley Capital LLC purchased a new position in shares of Molina Healthcare in the fourth quarter valued at $55,000. EverSource Wealth Advisors LLC grew its holdings in Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after buying an additional 88 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. increased its holdings in Molina Healthcare by 337.0% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock worth $58,000 after acquiring an additional 155 shares during the period. 98.50% of the stock is owned by institutional investors and hedge funds.
Molina Healthcare Stock Performance
NYSE MOH traded up $4.91 on Friday, hitting $298.39. 630,608 shares of the company traded hands, compared to its average volume of 686,529. The business's 50 day moving average price is $316.74 and its 200-day moving average price is $307.19. The company has a market capitalization of $16.17 billion, a price-to-earnings ratio of 14.61, a P/E/G ratio of 1.06 and a beta of 0.57. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $365.23.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. The firm had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. During the same quarter in the prior year, the business earned $5.73 earnings per share. Molina Healthcare's revenue for the quarter was up 12.2% on a year-over-year basis. Equities analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on MOH shares. Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $295.00 to $372.00 in a research note on Wednesday, March 5th. Mizuho raised their price target on shares of Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Wall Street Zen raised Molina Healthcare from a "hold" rating to a "buy" rating in a research note on Friday, April 11th. Sanford C. Bernstein initiated coverage on Molina Healthcare in a research report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price objective on the stock. Finally, Morgan Stanley assumed coverage on Molina Healthcare in a research note on Monday. They issued an "overweight" rating and a $364.00 price target on the stock. Nine analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $364.21.
Check Out Our Latest Report on Molina Healthcare
Insider Activity at Molina Healthcare
In other news, Director Richard M. Schapiro sold 669 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the transaction, the director now directly owns 11,244 shares of the company's stock, valued at $3,603,702. This represents a 5.62% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Joseph M. Zubretsky sold 87,500 shares of Molina Healthcare stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the sale, the chief executive officer now owns 257,715 shares in the company, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The disclosure for this sale can be found here. 1.26% of the stock is currently owned by corporate insiders.
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.